About this FactMed analysis covering adverse side effect reports of AGGRENOX patients who developed HYPERHIDROSIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 48 individuals taking AGGRENOX reported HYPERHIDROSIS to the FDA. A total of 3940 AGGRENOX drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AGGRENOX and HYPERHIDROSIS. In doing so, we compare AGGRENOX with other drugs that cause HYPERHIDROSIS, to help you evaluate whether or not AGGRENOX causes HYPERHIDROSIS. Likewise, this page shows the most highly-reported side effects of AGGRENOX, so you can see if HYPERHIDROSIS ranks among AGGRENOX's most well-known side effects.
Summary Statistics
Reports of AGGRENOX causing HYPERHIDROSIS: 48
Reports of any side effect of AGGRENOX : 3940
Percentage of AGGRENOX patients where HYPERHIDROSIS is a reported side effect: 1.2183%

FDA reports of any drug causing HYPERHIDROSIS : 40246
Average percentage for all medicated patients where HYPERHIDROSIS is reported as a complication: 0.2522%

Physician opinion on AGGRENOX as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AGGRENOX:
CEREBROVASCULAR ACCIDENT PROPHYLAXIS ( 573 patients )
TRANSIENT ISCHAEMIC ATTACK ( 426 patients )
CEREBROVASCULAR ACCIDENT ( 325 patients )
PROPHYLAXIS ( 114 patients )
DRUG USE FOR UNKNOWN INDICATION ( 81 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 80 patients )
ANTICOAGULANT THERAPY ( 71 patients )
THROMBOSIS PROPHYLAXIS ( 25 patients )
ANTIPLATELET THERAPY ( 24 patients )
ISCHAEMIC STROKE ( 14 patients )
CAROTID ARTERY OCCLUSION ( 14 patients )
HYPERTENSION ( 12 patients )
ISCHAEMIC CEREBRAL INFARCTION ( 11 patients )
ATRIAL FIBRILLATION ( 11 patients )
CORONARY ARTERY DISEASE ( 9 patients )
CEREBRAL INFARCTION ( 7 patients )
VASCULAR SHUNT ( 7 patients )
ARTERIAL DISORDER ( 7 patients )
THROMBOSIS ( 7 patients )
LACUNAR INFARCTION ( 6 patients )
CARDIAC DISORDER ( 5 patients )
PLATELET AGGREGATION ABNORMAL ( 5 patients )
ANGIOPATHY ( 5 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 5 patients )
CEREBRAL ISCHAEMIA ( 5 patients )
CEREBROVASCULAR DISORDER ( 4 patients )
CARDIOVASCULAR DISORDER ( 4 patients )
CEREBROVASCULAR INSUFFICIENCY ( 4 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 4 patients )
CAROTID ARTERY STENOSIS ( 3 patients )
HYPERHOMOCYSTEINAEMIA ( 3 patients )
HYPOAESTHESIA FACIAL ( 3 patients )
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT ( 3 patients )
EPILEPSY ( 3 patients )
COAGULOPATHY ( 3 patients )
HEMIPARESIS ( 3 patients )
DIZZINESS ( 3 patients )
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ( 2 patients )
PHLEBITIS SUPERFICIAL ( 2 patients )
VARICOSE VEIN ( 2 patients )
CAROTID ARTERY DISEASE ( 2 patients )
MIGRAINE ( 2 patients )
CEREBRAL HAEMORRHAGE ( 2 patients )
BLOOD PRESSURE ( 2 patients )
SPEECH DISORDER ( 2 patients )
PAIN ( 2 patients )
CEREBRAL THROMBOSIS ( 2 patients )
PERIPHERAL ISCHAEMIA ( 2 patients )
ARTERY DISSECTION ( 2 patients )
VASCULAR CALCIFICATION ( 2 patients )
CONVULSION ( 2 patients )
ANGINA PECTORIS ( 2 patients )
CEREBELLAR INFARCTION ( 2 patients )
POST PROCEDURAL STROKE ( 2 patients )
HYPOAESTHESIA ( 2 patients )
BLOOD DISORDER ( 2 patients )
HYPOPERFUSION ( 2 patients )
OPTIC NERVE INFARCTION ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
ENZYME ABNORMALITY ( 2 patients )
ESSENTIAL THROMBOCYTHAEMIA ( 1 patients )
ARTERIAL STENOSIS ( 1 patients )
THYROID STIMULATING IMMUNOGLOBULIN ( 1 patients )
FEELING ABNORMAL ( 1 patients )
ARTHRITIS ( 1 patients )
CEREBROVASCULAR STENOSIS ( 1 patients )
HAEMODILUTION ( 1 patients )
ATRIAL FLUTTER ( 1 patients )
CONCUSSION ( 1 patients )
MEMORY IMPAIRMENT ( 1 patients )
VASCULAR DEMENTIA ( 1 patients )
AMNESIA ( 1 patients )
PLATELET COUNT ( 1 patients )
BALANCE DISORDER ( 1 patients )
VASCULITIS ( 1 patients )
CEREBRAL ARTERIOSCLEROSIS ( 1 patients )
BASAL GANGLION DEGENERATION ( 1 patients )
DIALYSIS ( 1 patients )
MUSCULAR WEAKNESS ( 1 patients )
VERTIGO ( 1 patients )
OFF LABEL USE ( 1 patients )
AORTIC VALVE REPLACEMENT ( 1 patients )
HYPOTENSION ( 1 patients )
BRAIN STEM INFARCTION ( 1 patients )
EMBOLIC STROKE ( 1 patients )
ARRHYTHMIA ( 1 patients )
INFARCTION ( 1 patients )
THROMBOEMBOLIC STROKE ( 1 patients )
BRAIN STEM SYNDROME ( 1 patients )
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ( 1 patients )
ARTERIAL OCCLUSIVE DISEASE ( 1 patients )
ISCHAEMIA ( 1 patients )
CARDIOMYOPATHY ( 1 patients )
EYE DISORDER ( 1 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 1 patients )
PLASMA VISCOSITY DECREASED ( 1 patients )
AMAUROSIS FUGAX ( 1 patients )
PLATELET AGGREGATION INHIBITION ( 1 patients )
ATRIAL SEPTAL DEFECT REPAIR ( 1 patients )
MICROANGIOPATHY ( 1 patients )
HYPERLIPIDAEMIA ( 1 patients )
BASAL GANGLIA INFARCTION ( 1 patients )
DEEP VEIN THROMBOSIS ( 1 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 1 patients )
VASCULITIS CEREBRAL ( 1 patients )
CEREBRAL ATHEROSCLEROSIS ( 1 patients )
NERVOUS SYSTEM DISORDER ( 1 patients )
VISUAL IMPAIRMENT ( 1 patients )
ANXIETY ( 1 patients )
CEREBRAL HYPOPERFUSION ( 1 patients )
RUPTURED CEREBRAL ANEURYSM ( 1 patients )
BLOOD PRESSURE ABNORMAL ( 1 patients )
DYSARTHRIA ( 1 patients )
APHASIA ( 1 patients )
STENT PLACEMENT ( 1 patients )
BRAIN STEM ISCHAEMIA ( 1 patients )
PARAESTHESIA ( 1 patients )
INFLAMMATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPERHIDROSIS:

ASPIRIN (3357 patients)
HEPARIN SODIUM INJECTION (2359 patients)
VIOXX (1878 patients)
DURAGESIC-100 (1713 patients)
CYMBALTA (1702 patients)
PAXIL (1675 patients)
BYETTA (1448 patients)
LIPITOR (1340 patients)
SEROQUEL (1336 patients)
LISINOPRIL (1319 patients)
LYRICA (1309 patients)
SYNTHROID (1258 patients)
OXYCONTIN (1237 patients)
XANAX (1232 patients)
NEXIUM (1161 patients)
LANTUS (1158 patients)
REMICADE (1156 patients)
ATENOLOL (1082 patients)
SIMVASTATIN (1070 patients)
HUMIRA (1062 patients)
NEURONTIN (1051 patients)
NIASPAN (1049 patients)
ZOLOFT (1046 patients)
OMEPRAZOLE (977 patients)
PLAVIX (945 patients)
PREDNISONE (941 patients)
LASIX (932 patients)
METFORMIN HCL (906 patients)
LEXAPRO (904 patients)
HYDROCHLOROTHIAZIDE (869 patients)
ENBREL (815 patients)
AMBIEN (805 patients)
CELEBREX (784 patients)
FUROSEMIDE (777 patients)
ALBUTEROL (774 patients)
DIAZEPAM (766 patients)
EFFEXOR (759 patients)
FORTEO (756 patients)
ACETAMINOPHEN (748 patients)
FOLIC ACID (746 patients)
LEVOTHYROXINE SODIUM (740 patients)
CHANTIX (732 patients)
EFFEXOR XR (714 patients)
TOPROL-XL (714 patients)
DIGOXIN (710 patients)
FOSAMAX (702 patients)
IBUPROFEN (700 patients)
ZOCOR (692 patients)
PAROXETINE HCL (690 patients)
COUMADIN (685 patients)
PRILOSEC (669 patients)
PREVACID (662 patients)
METHOTREXATE (656 patients)
CRESTOR (649 patients)
CLONAZEPAM (649 patients)
LORAZEPAM (649 patients)
PROZAC (639 patients)
NORVASC (621 patients)
AVONEX (614 patients)
VITAMIN D (603 patients)
PROTONIX (601 patients)
PRISTIQ (595 patients)
PERCOCET (582 patients)
KLONOPIN (580 patients)
GABAPENTIN (572 patients)
VICODIN (570 patients)
WELLBUTRIN (564 patients)
TRAMADOL HCL (552 patients)
FENTANYL (543 patients)
FENTANYL-100 (534 patients)
ALPRAZOLAM (529 patients)
SANDOSTATIN LAR (528 patients)
POTASSIUM CHLORIDE (527 patients)
GLUCOPHAGE (527 patients)
HUMALOG (527 patients)
PREMARIN (520 patients)
OXYCODONE HCL (519 patients)
INSULIN (502 patients)
DIOVAN (501 patients)
ATIVAN (500 patients)
METOPROLOL TARTRATE (498 patients)
ZYPREXA (486 patients)
NITROGLYCERIN (481 patients)
VALIUM (476 patients)
HEPARIN SODIUM (474 patients)
AMITRIPTYLINE HCL (474 patients)
CITALOPRAM HYDROBROMIDE (473 patients)
SINGULAIR (458 patients)
TRAZODONE HCL (456 patients)
CALCIUM (456 patients)
ALLOPURINOL (447 patients)
LEVAQUIN (443 patients)
FENTANYL TRANSDERMAL SYSTEM (430 patients)
GLYBURIDE (429 patients)
SUBOXONE (427 patients)
COREG (420 patients)
ADVAIR DISKUS 100/50 (417 patients)
CELEXA (417 patients)
BENADRYL (412 patients)
MORPHINE (411 patients)
MULTI-VITAMIN (410 patients)
WARFARIN SODIUM (402 patients)
GLIPIZIDE (398 patients)
ACTOS (393 patients)
METOPROLOL (390 patients)
BACLOFEN (386 patients)
CLOZAPINE (385 patients)
CLOZARIL (379 patients)
METFORMIN (369 patients)
REBIF (368 patients)
KETEK (367 patients)
FLEXERIL (364 patients)
PREDNISONE TAB (363 patients)
LORTAB (362 patients)
MORPHINE SULFATE (360 patients)
TYSABRI (359 patients)
AMARYL (358 patients)
CLONIDINE (358 patients)
AVELOX (357 patients)
STRATTERA (356 patients)
FLUOXETINE (353 patients)
ZYRTEC (347 patients)
AVANDIA (346 patients)
MULTI-VITAMINS (346 patients)
ZOMETA (344 patients)
SOMA (344 patients)
RIBAVIRIN (343 patients)
ZOFRAN (340 patients)
OLANZAPINE (339 patients)
LEVOXYL (336 patients)
LAMICTAL (336 patients)
TYLENOL (CAPLET) (336 patients)
RISPERDAL (332 patients)
MIRTAZAPINE (328 patients)
AMLODIPINE (327 patients)
FISH OIL (322 patients)
TYLENOL (317 patients)
NAPROXEN (316 patients)
SIMCOR (316 patients)
ZANTAC (313 patients)
NOVOLOG (312 patients)
PEGASYS (311 patients)
DEXAMETHASONE (304 patients)
ALLEGRA (303 patients)
AMOXICILLIN (302 patients)
PREDNISOLONE (302 patients)
FLONASE (302 patients)
SAVELLA (298 patients)
DURAGESIC (298 patients)
METHADONE HCL (296 patients)
ENALAPRIL MALEATE (295 patients)
COZAAR (292 patients)
ABILIFY (292 patients)
ZETIA (289 patients)
RAMIPRIL (289 patients)
PROMETHAZINE (289 patients)
ASCORBIC ACID (283 patients)
LOPRESSOR (281 patients)
RANITIDINE (280 patients)
ACCUTANE (276 patients)
DILAUDID (273 patients)
HEPARIN (272 patients)
REGLAN (270 patients)
ZITHROMAX (267 patients)
SERTRALINE HYDROCHLORIDE (265 patients)
ALTACE (263 patients)
LANSOPRAZOLE (261 patients)
LIORESAL (261 patients)
SPIRIVA (258 patients)
VERAPAMIL (256 patients)
FLOMAX (256 patients)
CARVEDILOL (254 patients)
PROPRANOLOL (252 patients)
XOLAIR (251 patients)
PANTOPRAZOLE (250 patients)
PAROXETINE HYDROCHLORIDE (249 patients)
ACETYLSALICYLIC ACID SRT (248 patients)
AREDIA (248 patients)
PAXIL CR (247 patients)
PEG-INTRON (244 patients)
VITAMIN B-12 (244 patients)
ULTRAM (243 patients)
METOPROLOL SUCCINATE (236 patients)
DEPAKOTE (234 patients)
SPIRONOLACTONE (233 patients)
TEMAZEPAM (233 patients)
TRICOR (232 patients)
ELAVIL (226 patients)
ACTONEL (225 patients)
PEPCID (224 patients)
ATORVASTATIN CALCIUM (222 patients)
VYTORIN (221 patients)
CLARITIN (221 patients)
COLACE (216 patients)
METOCLOPRAMIDE (216 patients)
VENLAFAXINE HCL (215 patients)
GEODON (213 patients)
ZOLPIDEM (213 patients)
VITAMIN E (212 patients)
RISPERIDONE (211 patients)
CARBOPLATIN (211 patients)
SEROXAT (211 patients)
RITALIN (211 patients)
CALCIUM CARBONATE (210 patients)
VIAGRA (209 patients)
HYDROCODONE (208 patients)
TEGRETOL (208 patients)
REQUIP (207 patients)
MIRENA (207 patients)
GAMMAGARD LIQUID (206 patients)
Most common side effects for patients taking AGGRENOX:
HEADACHE (532 patients)
CEREBROVASCULAR ACCIDENT (466 patients)
NAUSEA (408 patients)
DIZZINESS (303 patients)
TRANSIENT ISCHAEMIC ATTACK (267 patients)
VOMITING (254 patients)
ASTHENIA (240 patients)
DIARRHOEA (234 patients)
FATIGUE (182 patients)
PAIN (176 patients)
FALL (170 patients)
PAIN IN EXTREMITY (149 patients)
DYSPNOEA (144 patients)
ANAEMIA (134 patients)
CHEST PAIN (130 patients)
RENAL FAILURE ACUTE (124 patients)
OEDEMA PERIPHERAL (122 patients)
ANXIETY (121 patients)
DEPRESSION (118 patients)
ABDOMINAL PAIN UPPER (113 patients)
HYPOAESTHESIA (112 patients)
HYPERTENSION (110 patients)
HYPOTENSION (105 patients)
MALAISE (104 patients)
CONFUSIONAL STATE (103 patients)
URINARY TRACT INFECTION (99 patients)
RENAL FAILURE (98 patients)
BACK PAIN (98 patients)
PNEUMONIA (96 patients)
WEIGHT DECREASED (95 patients)
ARTHRALGIA (94 patients)
GAIT DISTURBANCE (94 patients)
MYOCARDIAL INFARCTION (89 patients)
PYREXIA (89 patients)
DEHYDRATION (85 patients)
DRUG INEFFECTIVE (83 patients)
COUGH (83 patients)
MYALGIA (79 patients)
ATRIAL FIBRILLATION (79 patients)
CONVULSION (77 patients)
MUSCULAR WEAKNESS (77 patients)
DYSPHAGIA (76 patients)
LOSS OF CONSCIOUSNESS (76 patients)
PRURITUS (73 patients)
SOMNOLENCE (72 patients)
CONSTIPATION (72 patients)
CEREBRAL HAEMORRHAGE (72 patients)
FEELING ABNORMAL (72 patients)
INSOMNIA (71 patients)
ABDOMINAL PAIN (68 patients)
GASTROINTESTINAL HAEMORRHAGE (68 patients)
DECREASED APPETITE (67 patients)
RASH (67 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (66 patients)
HAEMORRHAGE (65 patients)
BLOOD PRESSURE INCREASED (65 patients)
DEATH (62 patients)
DYSPEPSIA (60 patients)
INJURY (59 patients)
BLOOD GLUCOSE INCREASED (59 patients)
SYNCOPE (59 patients)
ABDOMINAL DISCOMFORT (58 patients)
CEREBRAL INFARCTION (57 patients)
VISION BLURRED (57 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (57 patients)
HEMIPARESIS (56 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (56 patients)
RESPIRATORY FAILURE (55 patients)
MUSCLE SPASMS (54 patients)
CONTUSION (54 patients)
MEMORY IMPAIRMENT (54 patients)
NEUROPATHY PERIPHERAL (54 patients)
CARDIAC DISORDER (54 patients)
FLUSHING (53 patients)
HAEMOGLOBIN DECREASED (53 patients)
GASTRITIS (53 patients)
PARAESTHESIA (53 patients)
PALPITATIONS (52 patients)
SINUSITIS (50 patients)
RENAL FAILURE CHRONIC (50 patients)
DYSARTHRIA (50 patients)
EPISTAXIS (49 patients)
HYPERHIDROSIS (48 patients)
CARDIAC FAILURE CONGESTIVE (48 patients)
THROMBOCYTOPENIA (46 patients)
TREMOR (45 patients)
DYSGEUSIA (44 patients)
BALANCE DISORDER (44 patients)
CATARACT (43 patients)
SEPSIS (43 patients)
APHASIA (42 patients)
CORONARY ARTERY DISEASE (41 patients)
DEMENTIA (41 patients)
ABDOMINAL DISTENSION (40 patients)
SPEECH DISORDER (40 patients)
CONDITION AGGRAVATED (40 patients)
DIABETES MELLITUS (40 patients)
OFF LABEL USE (40 patients)
RETCHING (39 patients)
NECK PAIN (39 patients)
BLOOD PRESSURE DECREASED (39 patients)
WEIGHT INCREASED (38 patients)
BLOOD CHOLESTEROL INCREASED (38 patients)
ARTERIOSCLEROSIS (38 patients)
OSTEONECROSIS OF JAW (38 patients)
ATELECTASIS (38 patients)
EMOTIONAL DISTRESS (37 patients)
DIVERTICULUM (37 patients)
DYSPNOEA EXERTIONAL (37 patients)
DUODENAL ULCER (37 patients)
RECTAL HAEMORRHAGE (36 patients)
OSTEOPENIA (36 patients)
DEEP VEIN THROMBOSIS (36 patients)
RIB FRACTURE (36 patients)
CHEST DISCOMFORT (36 patients)
ANHEDONIA (35 patients)
URINARY INCONTINENCE (35 patients)
ABASIA (33 patients)
BLOOD CREATININE INCREASED (33 patients)
HYPERSENSITIVITY (33 patients)
ACUTE MYOCARDIAL INFARCTION (32 patients)
LUNG NEOPLASM MALIGNANT (32 patients)
VERTIGO (32 patients)
CARDIAC ARREST (32 patients)
HYPERLIPIDAEMIA (32 patients)
ERYTHEMA (31 patients)
MENTAL STATUS CHANGES (31 patients)
ISCHAEMIC STROKE (31 patients)
COLONIC POLYP (31 patients)
CAROTID ARTERY STENOSIS (31 patients)
TOOTHACHE (31 patients)
MUSCULOSKELETAL STIFFNESS (31 patients)
OVERDOSE (31 patients)
DYSPHONIA (31 patients)
TOOTH DISORDER (30 patients)
BLINDNESS (30 patients)
NIGHT SWEATS (30 patients)
AGEUSIA (29 patients)
LETHARGY (29 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (29 patients)
INFECTION (29 patients)
HAEMORRHOIDS (29 patients)
BRONCHITIS (29 patients)
URINARY RETENTION (29 patients)
DRY MOUTH (28 patients)
HAEMATURIA (28 patients)
HERPES ZOSTER (28 patients)
CYST (28 patients)
HYPOGLYCAEMIA (28 patients)
HALLUCINATION (28 patients)
HEAD INJURY (28 patients)
NEPHROLITHIASIS (28 patients)
RENAL CYST (28 patients)
EMPHYSEMA (27 patients)
HAEMATOMA (27 patients)
DISORIENTATION (27 patients)
THROMBOSIS (27 patients)
AMNESIA (27 patients)
FOOT FRACTURE (27 patients)
ANOREXIA (27 patients)
PLATELET COUNT DECREASED (27 patients)
INTERVERTEBRAL DISC DEGENERATION (27 patients)
GASTRITIS EROSIVE (27 patients)
CHILLS (27 patients)
ROTATOR CUFF SYNDROME (26 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (26 patients)
WHEEZING (26 patients)
HIP FRACTURE (26 patients)
DRUG INTERACTION (26 patients)
VISUAL IMPAIRMENT (26 patients)
FAECAL INCONTINENCE (25 patients)
SUBDURAL HAEMATOMA (25 patients)
CARDIOMEGALY (25 patients)
INCORRECT DOSE ADMINISTERED (25 patients)
CARDIO-RESPIRATORY ARREST (25 patients)
ORTHOSTATIC HYPOTENSION (25 patients)
CAROTID ARTERY OCCLUSION (25 patients)
BONE PAIN (25 patients)
MITRAL VALVE INCOMPETENCE (25 patients)
OSTEOARTHRITIS (25 patients)
HYPOKALAEMIA (25 patients)
HOT FLUSH (24 patients)
IRRITABLE BOWEL SYNDROME (24 patients)
PULMONARY FIBROSIS (24 patients)
SKIN TIGHTNESS (24 patients)
NOCTURIA (24 patients)
HYPERKALAEMIA (24 patients)
UNRESPONSIVE TO STIMULI (24 patients)
PLEURAL EFFUSION (24 patients)
OSTEOPOROSIS (24 patients)
HEART RATE INCREASED (24 patients)
JOINT SWELLING (24 patients)
TINNITUS (24 patients)
INFLUENZA LIKE ILLNESS (24 patients)
MIGRAINE (24 patients)
METABOLIC ACIDOSIS (23 patients)
RASH GENERALISED (23 patients)
ALANINE AMINOTRANSFERASE INCREASED (23 patients)
ALOPECIA (23 patients)
TACHYCARDIA (23 patients)
OESOPHAGITIS (23 patients)
INFLUENZA (23 patients)
HAEMATEMESIS (23 patients)
SPINAL OSTEOARTHRITIS (23 patients)
HYPERCALCAEMIA (23 patients)
COMA (23 patients)
CEREBRAL ATROPHY (23 patients)
SINUS BRADYCARDIA (23 patients)
AGITATION (22 patients)
TIBIA FRACTURE (22 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AGGRENOX


Issue Description / Topic Timestamp
QUESTION
NEUROPATHY
I am a 76 yr old female and take Aggrenox. Lately I have noticed numbness on the soles of both feet and above one knee to buttock and am trying to determine the cause. My doctor is guessing two pinched spinal nerves and has sent me to physical therapist. I've not noticed a change thus far and am trying to do my own sleuthing. Has anyone else had this reaction to the drug? 2014-11-21 20:22:34
QUESTION
MACULAR DEGENERATION
I've being taking aggrenox for a few years and although i'd recently was diagnosed with macular distrophy, i did not think aggrenox as a probable cause but on the other hand the Dr that diagnosed me told me that since there was no family history nor other facts like look at an eclipse directly etc he found no cause at so early age im 47, my question is, could be my problem a correlated cause of using this medicine, aggrenox? 2014-11-24 19:06:28
QUESTION
MACROGLOSSIA
I began taking Aggrenox Jan 2014. In approx June 2015 I was diagnosed with macroglossia - tongue swelling. Any chance it is caused by Aggrenox? I have been tested for allergies that was negative. Tongue is pushing on front teeth in sleep moving upper jaw significantly. Help! 2015-12-04 17:51:00
QUESTION
BURNING SENSATION
headackes and burning sensation over most of body. Can this be caused by taking Aggrenox? 2016-02-08 19:59:22
QUESTION
DRY MOUTH
Can aggrenox cause dry mouth? 2016-07-31 20:15:08

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPERHIDROSIS and AGGRENOX, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AGGRENOX, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AGGRENOX. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AGGRENOX experts. If you are a healthcare provider experienced in prescribing AGGRENOX, please register here.

Your online appointment book for Edenton Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use